Dr Rachelle Schwarz, DO | |
20 Prospect Ave, Suite 715, Hackensack, NJ 07601-1915 | |
(201) 342-1877 | |
Not Available |
Full Name | Dr Rachelle Schwarz |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 11 Years |
Location | 20 Prospect Ave, Hackensack, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487093472 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 25MB09932100 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Hackensack, NJ | Home health agency |
Hackensack University Medical Center | Hackensack, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hackensack Meridian Health Medical Group - Primary Care Pc | 7911003330 | 273 |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.
Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain.
› Verified 4 days ago
Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.
Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain.
› Verified 4 days ago
Entity Name | Hackensack Meridian Health Medical Group - Primary Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336203538 PECOS PAC ID: 7911003330 Enrollment ID: O20070502000000 |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.
Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rachelle Schwarz, DO 20 Prospect Ave, Suite 715, Hackensack, NJ 07601-1915 Ph: (201) 342-1877 | Dr Rachelle Schwarz, DO 20 Prospect Ave, Suite 715, Hackensack, NJ 07601-1915 Ph: (201) 342-1877 |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.
Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain.
› Verified 4 days ago
Kamal C Wagle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Essex St Ste 303, Hackensack, NJ 07601 Phone: 551-996-8100 | |
Dr. Dorothy Renee Ourvan, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Essex St, Hackensack, NJ 07601 Phone: 201-336-8686 Fax: 201-342-3546 | |
Dr. Marion Y Bobb-mckoy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 Summit Ave, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. Stefanos Pantagis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Main St, Hackensack, NJ 07601 Phone: 201-633-7375 Fax: 201-633-7361 | |
Dr. Arthur W Chaney Jr., M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 20 Prospect Ave, Suite 715, Hackensack, NJ 07601 Phone: 201-881-0721 Fax: 201-881-0725 | |
Miriam Hanna, Family Medicine Medicare: Medicare Enrolled Practice Location: 155 Polifly Rd Ste 301, Hackensack, NJ 07601 Phone: 201-343-6364 |